ReVein is specially formulated to promote the normal functioning of the circulatory system. IPH AVN short-chain peptide offers angioprotective and vasoprotective benefits to arteries, veins and capillaries.

ReVein’s proprietary formulation contains IPH AVN Short-chain peptides that activate AGT, AGTR2, ACE, NOS3, and MTHFR genes, for a healthy vascular system. ReVein was found to improve VEGF protein by a factor of 4.5.

ReVein’s other benefits include healthy hemodynamics through proper blood vessel health, artery quality and elasticity.

Contains Leucine, Valine and Isoleucine
Targeted, natural short-chain peptides
Each bottle contains 90 capsules (2 capsule servings)
Audited VeriGMP verified
Made in the USA
Gluten-Free
GMO-Free
Soy Free
Lactose-Free

Related Scientific Material on Peptide IPH AVN:

AngioProtective Effects of the Peptide IPH AVN
Scientific-Discussion # 33, (2019)

Ivko X.
Research scientist, Open Institute of Human and Nature, Lithuania, Vilnius

Olenskaya T.
Research scientist, Vitebsk State Medical University

Bocharova K.
Research scientist, Belgorod National Research University

Satardinova E.
Research scientist, Irkutsk State Medical Academy of postgraduate education

Abstract (edited into English with some alterations)

This article describes the result of biological and clinical protective effects of the peptide IPH AVN. The application of the peptide IPH AVN significantly increases in human cell culture a “cascade” of signal molecules, which is necessary for: the activation, proliferation and differentiation of stem cells in the cells of the vascular system; the formation of vascular system, regulation of metabolism in epithelial cells; the regulation of blood vessel tone; the smooth muscle development of the vascular wall and the prevention of thrombosis. The application of the peptide IPH AVN has a pronounced angioprotective nature in cell culture. The application of the peptide IPH AVN promotes the reparation of the arterial system after damage and may reduce clot formation based on experimental models. The application of the peptide IPH AVN leads to the optimization of vascular function and improvement of peripheral hemodynamics. The application of the peptide IPH AVN may improve the elasticity of the vascular wall, leading to the optimization of the functional activity of the peripheral blood circulation system according to clinical research.